Sort

Search

24/02/2022 Persons with first episode psychosis have distinct profiles of social cognition and metacognition (vol 9, 61, 2021)
Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Birules, I, Barajas, A, Lorente-Rovira, E, Diaz-Cutraro, L, Verdaguer, M, Garcia-Mieres, H, Sevilla-Llewellyn-Jones, J, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Huerta-Ramos, E, Pelaez, T, Barrigon, ML, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Moritz, S, Ochoa, S. Persons with first episode psychosis have distinct profiles of social cognition and metacognition (vol 9, 61, 2021). SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-021-00199-4. PMID:35210466. IF:5.400(Q2/3D).
23/02/2022 Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
Pinana, JL, Vazquez, L, Martino, R, de la Camara, R, Sureda, A, Rodriguez-Veiga, R, Garrido, A, Sierra, J, Ribera, JM, Torrent, A, Mateos, MV, de la Rubia, J, Tormo, M, Diez-Campelo, M, Garcia-Gutierrez, V, Alvarez-Larran, A, Sancho, JM, MartinGarcia-Sancho, A, Yanez, L, Simon, JAP, Barba, P, Abrisqueta, P, Alvarez-Twose, I, Bonanad, S, Lecumberri, R, Ruiz-Camps, I, Navarro, D, Hernandez-Rivas, JA, Cedillo, A, Garcia-Sanz, R, Bosch, F. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. LEUKEMIA & LYMPHOMA. 2022; 63(3)DOI:10.1080/10428194.2021.1992619. PMID:34668835. IF:2.600(Q3/7D).
22/02/2022 The ERA Registry Annual Report 2019: summary and age comparisons
Boenink, R, Astley, ME, Huijben, JA, Stel, VS, Kerschbaum, J, Ots-Rosenberg, M, Asberg, AA, Lopot, F, Golan, E, de la Nuez, PC, Camblor, MR, Trujillo-Aleman, S, San Millan, JCR, Mingo, PU, Diaz, JM, Bouzas-Caamano, ME, Artamendi, M, Madre, MA, de Pablos, CS, Roblero, MFS, Zurriaga, O, Stendahl, ME, Bell, S, Idrizi, A, Ioannou, K, Debska-Slizien, A, Galvao, AA, De Meester, JM, Resic, H, Hommel, K, Radunovic, D, Palsson, R, Lassalle, M, Finne, P, Bazaga, MD, Gjorgjievski, N, Seyahi, N, Bonthuis, M, Ortiz, A, Jager, KJ, Kramer, A. The ERA Registry Annual Report 2019: summary and age comparisons. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab273. PMID:35211303. IF:4.600(Q1/2D).
22/02/2022 CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome
Roca, N, Jatem, E, Abo, A, Santacana, M, Cruz, A, Madrid, A, Fraga, G, Martin, M, Gonzalez, J, Martinez, C, Balius, A, Segarra, A. CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab215. PMID:35211308. IF:4.600(Q1/2D).
22/02/2022 European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
Bataller, A, Garrido, A, Guijarro, F, Onate, G, Diaz-Beya, M, Arnan, M, Tormo, M, Vives, S, de Llano, MPQ, Coll, R, Gallardo, D, Vall-Llovera, F, Escoda, L, Garcia-Guinon, A, Salamero, O, Sampol, A, Merchan, BM, Bargay, J, Castano-Diez, S, Esteban, D, Oliver-Caldes, A, Rivero, A, Mozas, P, Lopez-Guerra, M, Pratcorona, M, Zamora, L, Costa, D, Rozman, M, Nomdedeu, JF, Colomer, D, Brunet, S, Sierra, J, Esteve, J. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol. Blood Advances. 2022; 6(4)DOI:10.1182/bloodadvances.2021005585. PMID:34911079. IF:7.500(Q1/2D).
21/02/2022 Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus
Stocchi, F, Antonini, A, Berg, D, Bergmans, B, Jost, W, Katzenschlager, R, Kulisevsky, J, Odin, P, Valldeoriola, F, Chaudhuri, KR. Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus. npj Parkinsons Disease. 2022; 8(1)DOI:10.1038/s41531-022-00277-z. PMID:35190544. IF:8.700(Q1/1D).
19/02/2022 Multi-level policy responses to tackle socioeconomic inequalities in the incidence of COVID-19 in a European urban area
Malmusi, D, Pasarin, MI, Mari-Dell'Olmo, M, Artazcoz, L, Diez, E, Tolosa, S, Rodriguez-Sanz, M, Perez, G, Pena-Gallardo, C, Borrell, C. Multi-level policy responses to tackle socioeconomic inequalities in the incidence of COVID-19 in a European urban area. International Journal for Equity in Health. 2022; 21(1)DOI:10.1186/s12939-022-01628-1. PMID:35183189. IF:4.800(Q1/2D).
18/02/2022 Endothelium-Released Microvesicles Transport miR-126 That Induces Proangiogenic Reprogramming in Monocytes
Arderiu, G, Pena, E, Civit-Urgell, A, Badimon, L. Endothelium-Released Microvesicles Transport miR-126 That Induces Proangiogenic Reprogramming in Monocytes. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.836662. PMID:35251029. IF:7.300(Q1/3D).
17/02/2022 Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity
Garcia-Beltran, C, Cereijo, R, Plou, C, Gavalda-Navarro, A, Malpique, R, Villarroya, J, Lopez-Bermejo, A, de Zegher, F, Ibanez, L, Villarroya, F. Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(3)DOI:10.1210/clinem/dgab761. PMID:34677618. IF:5.800(Q1/3D).
16/02/2022 Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients
Masana, L, Correig, E, Rodriguez-Borjabad, C, Anoro, E, Arroyo, JA, Jerico, C, Pedragosa, A, la Miret, M, Naf, S, Pardo, A, Perea, V, Perez-Bernalte, R, Plana, N, Ramirez-Montesinos, R, Royuela, M, Soler, C, Urquizu-Padilla, M, Zamora, A, Pedro-Botet, J. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients. European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(2)DOI:10.1093/ehjcvp/pvaa128. PMID:33135047. IF:7.100(Q1/1D).
15/02/2022 A Score to Assess Mortality After Percutaneous Mitral Valve Repair
Raposeiras-Roubin, S, Adamo, M, Freixa, X, Arzamendi, D, Benito-Gonzalez, T, Montefusco, A, Pascual, I, Nombela-Franco, L, Rodes-Cabau, J, Shuvy, M, Portoles-Hernandez, A, Godino, C, Caneiro-Queija, B, Lupi, L, Regueiro, A, Li, CH, Fernandez-Vazquez, F, Frea, S, Avanzas, P, Tirado-Conte, G, Paradis, JM, Peretz, A, Monivas, V, Baz, JA, Galasso, M, Branca, L, Sanchis, L, Asmarats, L, Garrote-Coloma, C, Angelini, F, Leon, V, Pozo, E, Alperi, A, Beeri, R, Cani, D, Sabate, M, Fernandez-Peregrina, E, Gualis, J, Bocchino, PP, Curello, S, Abu-Assi, E, Iniguez-Romo, A, Bedogni, F, Rubbio, AP, Testa, L, Grasso, C, Estevez-Loureiro, R. A Score to Assess Mortality After Percutaneous Mitral Valve Repair. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022; 79(6)DOI:10.1016/j.jacc.2021.11.041. PMID:35144748. IF:24.000(Q1/1D).
14/02/2022 Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View
Lee-Rueckert, M, Lappalainen, J, Kovanen, PT, Escola-Gil, JC. Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.777822. PMID:35237673. IF:3.600(Q2/5D).
09/02/2022 Cortical microstructure in primary progressive aphasia: a multicenter study
Illan-Gala, I, Montal, V, Borrego-Ecija, S, Mandelli, ML, Falgas, N, Welch, AE, Pegueroles, J, Santos-Santos, M, Bejanin, A, Alcolea, D, Dols-Icardo, O, Belbin, O, Sanchez-Saudinos, MB, Bargallo, N, Gonzalez-Ortiz, S, Llado, A, Blesa, R, Dickerson, BC, Rosen, HJ, Miller, BL, Lleo, A, Gorno-Tempini, ML, Sanchez-Valle, R, Fortea, J. Cortical microstructure in primary progressive aphasia: a multicenter study. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-00974-0. PMID:35139897. IF:9.000(Q1/1D).
09/02/2022 Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population
Cebrian-Cuenca, AM, Mata-Cases, M, Franch-Nadal, J, Mauricio, D, Orozco-Beltran, D, Consuegra-Sanchez, L. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population. European Journal of Preventive Cardiology. 2022; 28(18)DOI:10.1093/eurjpc/zwaa073. PMID:33733654. IF:8.300(Q1/2D).
09/02/2022 Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial
van Poppel, MNM, Corcoy, R, Hill, D, Simmons, D, Mendizabal, L, Zulueta, M, Simon, L, Desoye, G, Perez, JMA, Kautzky-Willer, A, Harreiter, J, Damm, P, Mathiesen, E, Jensen, DM, Andersen, LLT, Dunne, F, Lapolla, A, Dalfra, MG, Bertolotto, A, van Poppel, M, Jelsma, JGM, Snoek, FJ, Galjaard, S, Wender-Ozegowska, E, Zawiejska, A, Devlieger, R, DALI Core Investigator Grp. Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial. AMERICAN JOURNAL OF CLINICAL NUTRITION. 2022; 115(2)DOI:10.1093/ajcn/nqab347. PMID:34669935. IF:7.100(Q1/2D).
08/02/2022 Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?
Hughes, DA, Aguiar, P, Lidove, O, Nicholls, K, Nowak, A, Thomas, M, Torra, R, Vujkovac, B, West, ML, Feriozzi, S. Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?. Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02181-4. PMID:35135579. IF:3.700(Q2/4D).
08/02/2022 Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study
Wendel-Garcia, PD, Mas, A, Gonzalez-Isern, C, Ferrer, R, Manez, R, Masclans, JR, Sandoval, E, Vera, P, Trenado, J, Fernandez, R, Sirvent, JM, Martinez, M, Ibarz, M, Garro, P, Lopera, JL, Bodi, M, Yebenes-Reyes, JC, Triginer, C, Vallverdu, I, Baro, A, Bodi, F, Saludes, P, Valencia, M, Roche-Campo, F, Huerta, A, Cambra, FJ, Barbera, C, Echevarria, J, Penuelas, O, Mancebo, J, UCIsCAT Study Grp. Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study. CRITICAL CARE. 2022; 26(1)DOI:10.1186/s13054-022-03905-5. PMID:35135588. IF:15.100(Q1/2D).
08/02/2022 Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19
Pinana, JL, Garcia-Sanz, R, Martino, R, Garcia-Rao, M, Martin-Martin, GA, Risco-Galvez, I, Tormo, M, Martinez-Barranco, P, Marcos-Corrales, S, Calabuig, M, Conesa, V, Teruel, A, Ruiz-Perez, S, Solano, C, Navarro, D, Cedillo, A, Sureda, A. Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19. Blood Advances. 2022; 6(3)DOI:10.1182/bloodadvances.2021006326. PMID:34905620. IF:7.500(Q1/2D).
08/02/2022 Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
Onate, G, Bataller, A, Garrido, A, Hoyos, M, Arnan, M, Vives, S, Coll, R, Tormo, M, Sampol, A, Escoda, L, Salamero, O, Garcia, A, Bargay, J, Aljarilla, A, Nomdedeu, JF, Esteve, J, Sierra, J, Pratcorona, M. Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Advances. 2022; 6(3)DOI:10.1182/bloodadvances.2020004136. PMID:34516636. IF:7.500(Q1/2D).
08/02/2022 Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
Menghrajani, K, Gomez-Arteaga, A, Madero-Marroquin, R, Zhang, MJ, Bo-Subait, K, Sanchez, J, Wang, HL, Aljurf, M, Assal, A, Bacher, VU, Badawy, SM, Bejanyan, N, Bhatt, VR, Bredeson, C, Byrne, M, Castillo, P, Cerny, J, Chhabra, S, Ciurea, SO, DeFilipp, Z, Farhadfar, N, Gadalla, S, Gale, RP, Ganguly, S, Gowda, L, Grunwald, MR, Hashmi, S, Hildebrandt, G, Kanakry, CG, Kansagra, A, Khimani, F, Krem, M, Lazarus, H, Liu, HT, Martino, R, Michelis, FV, Nathan, S, Nishihori, T, Olsson, R, Reshef, R, Rizzieri, D, Rowe, JM, Savani, BN, Seo, S, Sharma, A, Solh, M, Ustun, C, Verdonck, LF, Hourigan, C, Sandmaier, B, Litzow, M, Kebriaei, P, Weisdorf, D, Zhang, YM, Tallman, MS, Saber, W. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances. 2022; 6(3)DOI:10.1182/bloodadvances.2021004881. PMID:34551064. IF:7.500(Q1/2D).